Mapping out biomarkers for Alzheimer disease.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

9 citing papers in PubMed.

1. High Resolution Discovery Proteomics Reveals Candidate Disease Progression Markers of Alzheimer's Disease in Human Cerebrospinal Fluid.PloS one · 2015
   Trial
2. Biological Evaluation ofPharmaceuticals (Basel, Switzerland) · 2023
   Article
3. Clinicopathological Correlation: Dopamine and Amyloid PET Imaging with Neuropathology in Three Subjects Clinically Diagnosed with Alzheimer's Disease or Dementia with Lewy Bodies.Journal of Alzheimer's disease : JAD · 2021
   Article
4. Variability in Language used on Social Media prior to Hospital Visits.Scientific reports · 2020
   Article
5. Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2016
   Review
6. Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease research.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2015
   Review
7. Stability of clinical etiologic diagnosis in dementia and mild cognitive impairment: results from a multicenter longitudinal database.American journal of Alzheimer's disease and other dementias · 2013
   Article
8. Cross-validation of brain structural biomarkers and cognitive aging in a community-based study.International psychogeriatrics · 2012
   Article
9. Neuroimaging after critical illness: implications for neurorehabilitation outcome.NeuroRehabilitation · 2012
   Review

Corrections and comments

• Comment on
  Association of plasma beta-amyloid level and cognitive reserve with subsequent cognitive decline.2011
• Comment on
  Use of florbetapir-PET for imaging beta-amyloid pathology.2011

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as